VERTEX PHARMACEUTICALS INCORPORATED

Lobbying client. Federal LDA filings.

Connected on the graph

Inbound (27)

date	from	type	amount	source
—	Kate Kalutkiewicz	lobbied_for	—	lda_lobbyist_client
—	Matthew O Schumaker	lobbied_for	—	lda_lobbyist_client
—	Joshua David Odintz	lobbied_for	—	lda_lobbyist_client
—	Swarna Vallurupalli	lobbied_for	—	lda_lobbyist_client
—	Kyle Hill	lobbied_for	—	lda_lobbyist_client
—	Adam Buckalew	lobbied_for	—	lda_lobbyist_client
—	Adam Buckalew	lobbied_for	—	lda_lobbyist_client
—	Hazen Clay Marshall	lobbied_for	—	lda_lobbyist_client
—	Michael Hayes	lobbied_for	—	lda_lobbyist_client
—	Laura Friedel	lobbied_for	—	lda_lobbyist_client
—	Veronica Jackson	lobbied_for	—	lda_lobbyist_client
—	Hannah Beth Cornwell	lobbied_for	—	lda_lobbyist_client
—	Monica Popp	lobbied_for	—	lda_lobbyist_client
—	Andrew Joseph Siracuse	lobbied_for	—	lda_lobbyist_client
—	Mike Mckay	lobbied_for	—	lda_lobbyist_client
—	E. Brandon Garrett	lobbied_for	—	lda_lobbyist_client
2026-01-01	ALSTON & BIRD LLP	lobbies_for	—	lda_filing
2026-01-01	VERTEX PHARMACEUTICALS INCORPORATED	lobbies_for	$1,140,000	lda_filing
2026-01-01	HOLLAND & KNIGHT LLP	lobbies_for	$20,000	lda_filing
2026-01-01	MARSHALL & POPP, LLC	lobbies_for	$60,000	lda_filing
2026-01-01	ALB SOLUTIONS	lobbies_for	—	lda_filing
2026-01-01	ALB SOLUTIONS	lobbies_for	$50,000	lda_filing
2026-01-01	EMPIRE CONSULTING GROUP	lobbies_for	$50,000	lda_filing
2026-01-01	SALT POINT STRATEGIES	lobbies_for	$10,000	lda_filing
2025-01-01	MARSHALL & POPP, LLC	lobbies_for	—	lda_filing
2025-01-01	SALT POINT STRATEGIES	lobbies_for	—	lda_filing
2025-01-01	MCLARTY INBOUND LLC	lobbies_for	—	lda_filing

Outbound (8)

date	type	to	amount	role	source
2026-01-01	lobbies_on_bill	HR 1227 — Alternatives to PAIN Act	—	H.R. 1227	lobbying_bill_mention
2026-01-01	lobbies_on_bill	HR 1414 — Cameron’s Law	—	H.R. 1414	lobbying_bill_mention
2026-01-01	lobbies_on_bill	HR 1518 — New Era of Preventing End-Stage Kidney Disease Act	—	H.R. 1518	lobbying_bill_mention
2026-01-01	lobbies_on_bill	HR 6423 — HELP Copays Act	—	H.R. 6423	lobbying_bill_mention
2026-01-01	lobbies_on_bill	S 475 — Alternatives to PAIN Act	—	S. 475	lobbying_bill_mention
2026-01-01	lobbies_on_bill	HR 1227 — Alternatives to PAIN Act	—	H.R. 1227	lobbying_bill_mention
2026-01-01	lobbies_on_bill	S 475 — Alternatives to PAIN Act	—	S.475	lobbying_bill_mention
2026-01-01	lobbies_on_bill	HR 1227 — Alternatives to PAIN Act	—	HR 1227	lobbying_bill_mention

Source id: 63465
General description: Biopharmaceutical Company
State: MA
Country: US
Principal place of business: US
Effective date: 2024-11-12
Total spend (across 1 ingested filings): $20,000

Filings

Posted	Type	Year	Lobbying firm	Income
2026-04-10	`Q1`	2026	HOLLAND & KNIGHT LLP	$20,000

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.